Hernández- Bautista VM

Language: Spanish
References: 5
Page: 317-318
PDF size: 258.48 Kb.

Text Extraction

no abstract.

REFERENCES

1. Bruton OC. Agammaglobulinemia. Pediatrics. 1952;9(6):722-728.

2. Ballow M. Safety of IGIV therapy and infusion-related adverse events. Immunol Res. 2007;38:122-132.

3. Berger M. Subcutaneous Administration of IgG. Immunol Allergy Clin N Am. 2008;28:779-802.

4. Haddad A, Barnes D, Kafal A. Home therapy with subcutaneous immunoglobulins for patients with primary immunodeficiency diseases. Transfus Apher Sci. 2012;46(3):315-321.

5. Berger M. Choices of IgG replacement therapy for primary immune deficiency diseases: subcutaneous IgG vs intravenous IgG and selecting an optimal dose. Curr Opin Allergy Clin Immunol. 2011;11:532-538.